Articles

Walgreens’ stock jumps after earnings beat, dividend cut to boost cash flow

Walgreens Boots Alliance's stock rallied Thursday, after the drugstore chain and healthcare services company beat fiscal first-quarter earnings expectations, and nearly halved its dividend to bolster its cash position.

Jobless claims drop to nearly three-month low of 202,000

The number of Americans who applied for unemployment benefits in the final week of 2023 fell to a nearly three-month low, suggesting that a softening labor market still has plenty of residual strength.

I’m leaving Seattle for a job and better weather. Rental income won’t cover the 1.9% mortgage on our home. Should I sell?

"I’m skeptical our home will rent for $4,000, but I was wondering if making up the difference to keep this low mortgage rate doesn’t seem like a crazy idea."

Conagra’s stock drops as Q2 revenue and 2024 outlook fall short of analyst estimate

Food giant cites "challenging" economy despite lower inflation impact.

Why ‘Dry January’ is a bad idea

There can be benefits to going without alcohol for a short period, but plenty of caveats and cautions still apply.

Bond investors, don’t get fooled: this rebound is just a bear-market rally

Investor returns hinge on better-than-expected fed funds rate changes.

‘I discovered a lot of shady business practices’: I left my job due to the company’s lack of ethics. I want to blow the whistle, but I signed an NDA. What can I do?

"The company I left is OK with getting paid monthly for services even if they never had the capability or intention of following through with those services."

Ozempic parent Novo Nordisk to collaborate with Omega and Cellarity on obesity treatments

Omega's stock soared 90% premarket Thursday on news of a cooperation agreement with Ozempic parent Novo Nordisk.

Sharing COVID therapy secrets is a Trojan horse that would gut U.S. biotech

IP waiver would allow developing countries access to formulas and manufacturing details.

Why the S&P 500 is destined to keep crushing the Russell 2000

'Winner-take-all' economy favors large-cap stocks over small- and midcaps.

Mobileye’s stock melts down as inventory issues prompt grim revenue warning

The company disclosed that it has "become aware of excess inventory at our customers," representing an estimated 6 million to 7 million units of the company's EyeQ product.

Ozempic and other weight-loss drugs’ popularity set these stocks up for big gains

Gut-punch to medical technology and processed-food stocks is temporary.
1 863 864 865 866 867 1,571